Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 8-Oxoguanine modifications in peripheral leukocyte microRNAs promote age-related inflammation by remodeling gene regulatory networks. | Free Radic Biol Med | 2025 | 40288701 | PubTator, text mining | PubMed |
| Pre-transplant inflammation and its associations with acute GvHD and mortality in pediatric allogeneic hematopoietic stem cell transplantation patients. | Bone Marrow Transplant | 2025 | 40234725 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial analysis identifies context-dependent myeloid-T cell interactions in head and neck cancer immune checkpoint blockade response. | bioRxiv | 2025 | 40196610 | PubTator, text mining | PubMed |
| A Positive Feedback Loop Between CXCL16 and the Inflammatory Factors IL-17A and TGF-β Promotes Large Artery Atherosclerosis by Activating the STAT3/NF-κB Pathway. | Cardiovasc Ther | 2025 | 40165931 | PubTator, text mining | PubMed |
| Leveraging Vitamin C to Augment Nanoenabled Photothermal Immunotherapy. | ACS Nano | 2025 | 40138545 | PubTator, text mining | PubMed |
| Circulating white blood cell traits, chemokines and small cell lung cancer risk: a Mendelian randomization study. | Transl Cancer Res | 2025 | 40104710 | PubTator, text mining | PubMed |
| Deciphering the IgG Idiotype Network Through Proteomic Analysis of Potential Targets in SARS-CoV-2-Induced Immune Responses. | Immunology | 2025 | 40077865 | PubTator, text mining | PubMed |
| CXCL16 knockout inhibit asthma airway inflammation by suppressing H2-DM molecular mediated antigen presentation. | Cell Death Discov | 2025 | 40050290 | PubTator, text mining | PubMed |
| The CXCR6-CXCL16 axis mediates T cell control of polyomavirus infection in the kidney. | PLoS Pathog | 2025 | 40043065 | PubTator, text mining | PubMed |
| Therapeutic evaluation of Wumei Pill (WP) for nocturnal asthma in Bmal1 gene knockout mice. | J Asthma | 2025 | 39976370 | PubTator, text mining | PubMed |
| Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system. | Front Endocrinol (Lausanne) | 2025 | 39944203 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals cholesterol metabolism-related signature for predicting prognosis and guiding individualized treatment of glioma. | Heliyon | 2025 | 39866460 | PubTator, text mining | PubMed |
| Sprouting sympathetic fibres release CXCL16 and norepinephrine to synergistically mediate sensory neuronal hyperexcitability in a rodent model of neuropathic pain. | Br J Anaesth | 2025 | 39848871 | PubTator, text mining | PubMed |
| Circulating chemokine levels and receptor polymorphisms have potential as biomarkers for fibrosis stages in patients with chronic hepatitis C infection. | Mol Biol Rep | 2025 | 39825971 | PubTator, text mining | PubMed |
| Epithelial and mesenchymal compartments of the developing bladder and urethra display spatially distinct gene expression patterns. | Dev Biol | 2025 | 39798644 | PubTator, text mining | PubMed |
| Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice. | Aging (Albany NY) | 2025 | 39792466 | PubTator, text mining | PubMed |
| Comprehensive analysis of heterogeneity and cell-cell interactions in Crohn's disease reveals novel location-specific insights. | J Adv Res | 2025 | 39732334 | PubTator, text mining | PubMed |
| Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial. | EBioMedicine | 2025 | 39731852 | PubTator, text mining | PubMed |
| CXCL16/CXCR6/TGF-β Feedback Loop Between M-MDSCs and Treg Inhibits Anti-Bacterial Immunity During Biofilm Infection. | Adv Sci (Weinh) | 2025 | 39716908 | PubTator, text mining | PubMed |
| Circulating inflammatory markers predict depressive symptomatology in COVID-19 survivors. | Cytokine | 2025 | 39700666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=10